目的:观察施图伦滴眼液治疗幼儿散光的临床效果。方法:采用前瞻、随机、对照方法,将80例行阿托品眼膏散瞳验光的3～7岁,有1D以上散光患者,随机分成两组。40例应用施图伦滴眼液3mo,另40例为空白对照组。两组均在阿托品散瞳验光3mo后再次进行阿托品散瞳验光,比较两组3mo前后屈光状态差异,同时观察药物不良反应,以及每分钟眨眼次数。结果:用药前与用药3mo后比较,患者散光度减小差异有显著性,P<0.05。每分钟眨眼次数有减少。用药组未诉有任何不良反应。结论:施图伦治疗幼儿散光效果确切,且安全方便。

AIM:To observe the curative effect of augentropfen stulln mono on astigmatism in early childhood.METHODS:In a prospective,randomized and controlled method,by atropine eye ointment cycloplegic refraction,80 cases in 3-7 years old with more than 1D astigmatism were randomly divided into two groups.40 cases were applied augentropfen stulln mono 3-4 times per day for 3 months,and the other 40 cases were taken as control group.After 3 months,both groups were taken atropine mydriasis optometry again,the refractive status were compared before and after using the drops,and adverse drug reactions were observed,the number of times per minute blink were counted.RESULTS:After 3 months treatment,astigmatism was significantly reduced compared with before treatment(P<0.05).A decrease in the number of blinks per minute was also observed.Drug group did not have any adverse reactions.CONCLUSION:The treatment of astigmatism with augentropfen stulln mono in early childhood is safe,convenient and effective.

R774.5